A rapid method for detecting the predominant Ashkenazi Jewish mutation in the Bloom's syndrome gene

被引:0
|
作者
Straughen, JE
Johnson, J
McLaren, D
Proytcheva, M
Ellis, N
German, J
Groden, J
机构
[1] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA
[2] New York Blood Ctr, Lab Human Genet, New York, NY 10021 USA
关键词
Bloom's syndrome; mutation detection; Ashkenazi Jewish; DNA screening; carrier detection; Jewish genetic diseases;
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Bloom's syndrome (BS) is a rare, autosomal recessive disease characterized by sun sensitivity, short stature, and predisposition to cancer. Although rare in the general population, BS is more common in the Ashkenazi Jewish population (German, 1993). The isolation of the gene for BS, known as BLM, has permitted the identification of mutations within the gene and the discovery that most BS individuals of Ashkenazi Jewish origin carry the identical 6-bp deletioin/7-bp insertion at position 2,281 of BLM (blm(Ash)). We have developed a rapid method for detecting blm(Ash) based on restriction enzyme digestion of a PCR product containing the mutation. blm(Ash) creates a restriction site within the amplified fragment allowing distinction of normal and mutant DNAs. This method has been designed for use with genomic DNA or cDNA. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:175 / 178
页数:4
相关论文
共 50 条
  • [31] The Ala53Thr point mutation in the alpha-synuclein gene is absent in Ashkenazi Jewish patients with familial or sporadic Parkinson's disease
    Goldfarb, LG
    Lee, HS
    Isaacson, S
    Chapman, J
    Gorokhova, S
    Cervenakova, L
    NEUROLOGY, 1998, 50 (04) : A119 - A119
  • [32] Frequency of the Glucocerebrosidase N370S mutation and susceptibility to Parkinson's Disease in a cohort of ashkenazi Jewish ethnicity.
    Clark, LN
    Nicolai, A
    Harris, J
    Mejia-Santana, H
    Cote, LJ
    Louis, ED
    Fahn, S
    Marder, K
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 510 - 510
  • [33] The V281L mutation in the CYP21 gene is a founder mutation that is prevalent among individuals of Ashkenazi Jewish and European ancestry.
    Edelmann, L
    Kornreich, R
    Desnick, RJ
    Diaz, GA
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 370 - 370
  • [34] Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer
    S Lehrer
    F Fodor
    RG Stock
    NN Stone
    C Eng
    HK Song
    M McGovern
    British Journal of Cancer, 1998, 78 : 771 - 773
  • [35] RAPID NONRADIOACTIVE TRACER METHOD FOR DETECTING CARRIERS OF THE MAJOR ASHKENAZI JEWISH TAY-SACHS DISEASE MUTATIONS (CLINICAL-CHEMISTRY, VOL 38, PG 2249, 1992)
    STRASBERG, PM
    CLARKE, JTR
    CLINICAL CHEMISTRY, 1993, 39 (02) : 371 - 371
  • [36] Bloom's syndrome gene product is a DNA helicase, indeed!
    Gilgenkrantz, S
    M S-MEDECINE SCIENCES, 1996, 12 (03): : 403 - 404
  • [37] The Bloom's syndrome gene product interacts with topoisomerase III
    Wu, L
    Davies, SL
    North, PS
    Goulaouic, H
    Riou, JF
    Turley, H
    Gatter, KC
    Hickson, ID
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (13) : 9636 - 9644
  • [38] Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer
    Lehrer, S
    Fodor, F
    Stock, RG
    Stone, NN
    Eng, C
    Song, HK
    McGovern, M
    BRITISH JOURNAL OF CANCER, 1998, 78 (06) : 771 - 773
  • [39] Mutation analysis of the aspartoacylase gene in non-Ashkenazi Jewish patients with Canavan disease: Identification of 6 new mutations.
    Sistermans, EA
    van Beerendonk, HM
    de Coo, RFM
    Kleijer, WJ
    van Oost, BA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A346 - A346
  • [40] Simplified and rapid assay for detecting the 3′A mutation of the SDF-1 gene
    Hiratsuka, M
    Hishinuma, T
    Agatsuma, Y
    Inoue, T
    Omori, F
    Kishikawa, Y
    Mizugaki, M
    CLINICA CHIMICA ACTA, 2000, 294 (1-2) : 193 - 197